- Current report filing (8-K)
08 Januar 2013 - 12:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of
1934
Date of Report (Date of earliest event reported): January 5, 2013
Kewaunee Scientific Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
0-5286
|
|
38-0715562
|
(State or other jurisdiction
of incorporation or organization)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
2700 West Front Street
Statesville, NC 28677
(Address of principal executive offices) (Zip
Code)
Registrants telephone number, including area code: (704) 873-7202
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Patrick L. McCrory resigned as a director of Kewaunee Scientific Corporation (the Company) on
January 5, 2013, the day he was sworn in as Governor of North Carolina.
Item 5.03.
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
The Board of Directors of the Company had previously approved an amendment to Section 5.02 of the Bylaws of the Company to decrease the number of directors of the Companys Board of Directors
from seven (7) to six (6), with such amendment to be effective upon the resignation of Mr. McCrory as a director on January 5, 2013. A copy of the Companys Bylaws, as amended, is filed as Exhibit 3 hereto and incorporated
by reference herein.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits
|
|
|
Exhibit
Number
|
|
Description
|
3
|
|
Bylaws of the Company, as amended January 5, 2012.
|
Page - 1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 7, 2013
|
|
|
Kewaunee Scientific Corporation
|
|
|
By:
|
|
/s/ D. Michael Parker
|
|
|
D. Michael Parker
Senior
Vice President, Finance and
Chief Financial Officer
|
Page - 2
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jul 2023 bis Jul 2024